News
GLP-1 Prescriptions for New Mothers Have Increased Sharply
October 1, 2026
Featured Experts: Sih-Ting Cai, PhD
Research
All Research Featured Research
Issue Brief
The Relationship Between GLP-1 Use and Trust in Pharmaceutical Companies
September 14, 2026
Featured Experts: Wändi Bruine de Bruin, MSc, PhD, Alison Sexton Ward, PhD, Dana Goldman, PhD
Case Study
Schaeffer Solutions: Addressing the Obesity Crisis
June 25, 2026
Featured Experts: Dana Goldman, PhD, Darius Lakdawalla, PhD, Alison Sexton Ward, PhD, Erin Trish, PhD, Bryan Tysinger, PhD, PhuongGiang Nguyen, MSPH
Journal Article
GLP-1 Therapy and the Reshaping of Socioeconomic Gradients in Health
June 8, 2026
Featured Experts: J. Felipe Montano-Campos, PhD, Bryan Tysinger, PhD, Dana Goldman, PhD, Darius Lakdawalla, PhD
News
Revamping Public Housing May Help Reduce Childhood Obesity
April 17, 2026
Featured Experts: Victoria Shier, PhD
Perspective
The Case for Expanding Access to Weight-Loss Medications
March 12, 2026
Featured Experts: Alison Sexton Ward, PhD
News
White House Move to Expand Obesity Drug Access Informed by Schaeffer Research
November 10, 2025
Evidence Base
A Value-Based Price for Anti-Obesity Medications
July 17, 2025
Featured Experts: Alison Sexton Ward, PhD, Dana Goldman, PhD
Journal Article
Proposal for a Value-Based Agreement to Reimburse Anti-Obesity Medicines in Traditional Medicare
July 11, 2025
Featured Experts: Alison Sexton Ward, PhD, Erin Trish, PhD, Dana Goldman, PhD, Darius Lakdawalla, PhD
Evidence Base
A Diabetes Paradox: Better Health, But Still Out of Work
June 24, 2025
Featured Experts: Jack M. Chapel, PhD
Perspective
A Missed Chance to Make America Healthier and Richer
April 7, 2025
Featured Experts: Alison Sexton Ward, PhD, Dana Goldman, PhD
White Paper
Lifetime Social Returns From Expanding Access to Anti-Obesity Medications
March 27, 2025
Featured Experts: Alison Sexton Ward, PhD, Bryan Tysinger, PhD, PhuongGiang Nguyen, MSPH, Darius Lakdawalla, PhD, Dana Goldman, PhD
Comment Letter
Comments to CMS on Proposed Medicare and Medicaid Coverage of Anti-Obesity Medications
January 27, 2025
Featured Experts: Dana Goldman, PhD, Bryan Tysinger, PhD, Alison Sexton Ward, PhD
Perspective
Medicare Should Cover Wegovy — But Not Negotiate Its Price
January 17, 2025
Featured Experts: Joseph Grogan, JD
Perspective
Government Needs to Do More to Ensure Obesity Drug Safety
December 16, 2024
Featured Experts: Joseph Grogan, JD
Perspective
I’m a Doctor in East L.A. and Beverly Hills. I Want to Treat Obesity the Same Way in Both Places
October 28, 2024
Featured Experts: Anne Peters, MD
Evidence Base
The CBO Report on Medicare and Anti-Obesity Medications Should Not Be the Final Word
October 10, 2024
Featured Experts: Alison Sexton Ward, PhD
News
Growing Divide: Rural Men Are Living Shorter, Less Healthy Lives Than Their Urban Counterparts
September 25, 2024